Today’s Forbes CFO newsletter focuses on Aradhana Sarin’s journey from treating patients to becoming what she calls a ...

STORY: Donald Trump says he will soon place a “small” tariff on imported drugs - but the levies won’t stay low for long.The U.S. president said Tuesday (August 5) that he would announce the duties for ...

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an expansion of its partnership with AstraZeneca ...

Vivani Medical Inc. (NASDAQ:VANI) on Tuesday reported results from the LIBERATE-1 Phase 1 study of the exenatide GLP-1 ...

The market report provides current cardiotoxicity treatment practices, emerging drugs, market share of individual therapies, ...

Operating expenses decreased sharply compared to Q2 2024, supporting a cash runway into the second quarter of 2026. - Dose expansion enrollment was completed for the lead product in its main clinical ...

While a substantial portion of pipeline assets are externally sourced, many Big Pharmas are tapping into incubators and ...

One of Trump's demands was that the CEOs' companies limit drug costs for states' Medicaid plans to "most-favored nation" ...

The administration wants drugmakers to bring medication prices more closely in line with the Most-Favored Nation pricing approach.

For outsourcing and manufacturing professionals, 2024 may be remembered as the year capacity and partnerships took center ...

The "High Protein Jelly Pudding with Modified Texture for the Elderly with Swallowing Difficulties" by Asst. Prof. Dr.

“We’ll be putting initially a small tariff on pharmaceuticals but in one year—one and a half years maximum—it’s going to go ...